Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantat (Q84533304)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 July 2011

Language	Label	Description	Also known as
English	Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantat	scientific article published on 11 July 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

Charles Craddock

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

author name string

S W Bokhari

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

L Watson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

S Nagra

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

N H Russell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

publication date

11 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

528-534

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21743502 AND SRC:MED&resulttype=core&format=json

7 February 2020

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia in the elderly: conventional and novel treatment approaches

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of comorbidity indexes on non-relapse mortality.

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

A modified comorbidity index for hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.138

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84533304&oldid=2221607805"